Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663

Watchlist Manager
Bharat Immunologicals and Biologicals Corporation Ltd Logo
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Watchlist
Price: 23.32 INR -0.81% Market Closed
Market Cap: 1B INR
Have any thoughts about
Bharat Immunologicals and Biologicals Corporation Ltd?
Write Note

Relative Value

524663 doesn't have a meaningful market cap.

The Relative Value of one BIBCL stock under the Base Case scenario is 8.52 INR. Compared to the current market price of 23.32 INR, Bharat Immunologicals and Biologicals Corporation Ltd is Overvalued by 63%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIBCL Relative Value
Base Case
8.52 INR
Overvaluation 63%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
11
vs Industry
37
Median 3Y
2.9
Median 5Y
2.4
Industry
8.1
vs History
vs Industry
Median 3Y
-7.4
Median 5Y
-7.7
Industry
23
vs History
11
vs Industry
12
Median 3Y
9
Median 5Y
4.1
Industry
23.4
vs History
vs Industry
6
Median 3Y
-48.3
Median 5Y
-33.1
Industry
27.3
vs History
50
vs Industry
51
Median 3Y
1.4
Median 5Y
1.6
Industry
2.6
vs History
11
vs Industry
25
Median 3Y
4.1
Median 5Y
3.3
Industry
8.1
vs History
vs Industry
19
Median 3Y
-14.2
Median 5Y
-15.3
Industry
9.6
vs History
vs Industry
Median 3Y
-10.8
Median 5Y
-10.8
Industry
4.3
vs History
vs Industry
Median 3Y
-10.7
Median 5Y
-10.7
Industry
3.8
vs History
11
vs Industry
9
Median 3Y
14.6
Median 5Y
3.9
Industry
6
vs History
11
vs Industry
7
Median 3Y
14.6
Median 5Y
3.9
Industry
3.8
vs History
46
vs Industry
58
Median 3Y
1
Median 5Y
1.1
Industry
4.8

Multiples Across Competitors

BIBCL Competitors Multiples
Bharat Immunologicals and Biologicals Corporation Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
1B INR 13.2 -5.4 -8.3 -8.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 678 545.3 -179 080.5 -217 460.8 -214 979.3
US
Abbvie Inc
NYSE:ABBV
299.8B USD 5.4 59 14.8 22.7
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.6 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.7B USD 11.7 -259.9 26.3 27.6
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD 4.1 910.9 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 869.7 -477.1 -519.6 -505.7
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.5 20.7 25.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
86.2B USD 6.2 18.5 17 18.9
US
Seagen Inc
F:SGT
39.3B EUR 18 -55.2 -59.4 -53.6
NL
argenx SE
XBRU:ARGX
34B EUR 18.4 -129.2 -103.9 -75.7
P/E Multiple
Earnings Growth
IN
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Average P/E: 211.9
Negative Multiple: -5.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 080.5 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.6
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -259.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -477.1 N/A
AU
CSL Ltd
ASX:CSL
33.5
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.2 N/A
EV/EBITDA Multiple
EBITDA Growth
IN
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Average EV/EBITDA: 17.7
Negative Multiple: -8.3
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 460.8 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.3
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -519.6 N/A
AU
CSL Ltd
ASX:CSL
20.7
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -103.9 N/A
EV/EBIT Multiple
EBIT Growth
IN
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Average EV/EBIT: 23
Negative Multiple: -8.2
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 979.3 N/A
US
Abbvie Inc
NYSE:ABBV
22.7
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.6
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
AU
CSL Ltd
ASX:CSL
25.8
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -75.7 N/A

See Also

Discover More
Back to Top